ArticleCerebral cortex (New York, N.Y. : 1991)2025
The role of etiology in the identification of clinical markers of consciousness: comparing EEG alpha power, complexity, and spectral exponent.
Article in Cerebral cortex (New York, N.Y. : 1991), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Aperiodic Neural Activity in Clinical Investigations.The European journal of neuroscience · 2025Pooled it
- Reframing "paradoxical" excitation: disentangling electroencephalogram complexity and entropy reveals resting-state dynamics associated with propofol susceptibility in healthy adults.British journal of anaesthesia · 2026Article
- An experimental study of the effect of neuromuscular blockade on EEG-based measures of awareness.Scientific reports · 2026Article
- Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness.Brain : a journal of neurology · 2026Article
- EEG Response to Sedation Interruption Complements Behavioral Assessment After Severe Brain Injury.Annals of clinical and translational neurology · 2025Article
- Altered periodic and aperiodic activities in patients with disorders of consciousness.Frontiers in neuroscience · 2025Article
- Spectral peak analysis and intrinsic neural timescales as markers for the state of consciousness.NeuroImage. Clinical · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In the search for EEG markers of human consciousness, alpha power has long been considered a reliable marker which is fundamental for the assessment of unresponsive patients from all etiologies. However, recent evidence questioned the role of alpha power as a marker of consciousness and proposed the spectral exponent and spatial gradient as more robust and generalizable clinical indexes. In this study, we analyzed a large-scale dataset of 303 unresponsive patients and investigated etiology-specific differences in clinical markers of level of consciousness, responsiveness and capacity to recover. We compare a set of candidate EEG makers: i) absolute, relative and flattened alpha power; ii) spatial ratios; iii) the spectral exponent; and iv) signal complexity. Our results support the claim that alpha power has higher diagnostic value for anoxic patients. Meanwhile, the spectral slope showed diagnostic value for non-anoxic patients only. Changes in relative power and signal complexity occurred alongside changes in the spectral slope. Grouping unresponsive patients from different etiologies together can confound or obscure the diagnostic value of different EEG markers of consciousness. Our study highlights the importance of analyzing different etiologies independently and emphasizes the need to develop clinical markers which better account for inter-individual and etiology-dependent differences.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.